Navigation Links
Malaria No More Congratulates President-elect Obama and the New Congress and Urges Them to Uphold Their Strong Commitment to Eliminating Malaria
Date:11/5/2008

NEW YORK, Nov. 5 /PRNewswire/ -- The following is a statement from Peter Chernin, Chairman of Malaria No More, and Scott Case, CEO of Malaria No More on the 2008 election results:

Malaria No More congratulates President-elect Barack Obama on his victory last night and looks forward to working with the new Administration and the new Congress in continuing the global fight against malaria. The United States has been a leader in the fight and we know that both President-elect Obama and Vice President-elect Biden are dedicated to ensuring that our country remains strong in its commitment to ending malaria.

The new President and Congress will face serious economic challenges when assuming office. They will be asked to make tough decisions based on return on investment. From an economic, humanitarian and diplomatic perspective, there is perhaps no greater return on investment than funding efforts to defeat malaria. President-elect Obama recognized this when he endorsed the global malaria community's goal of ending malaria deaths by 2015 and put forth a solid framework to ensure that we not only continue to make progress but, ultimately, eliminate malaria across the globe.

As chief co-sponsor of the historic PEPFAR legislation passed last July, Vice President-elect Biden knows the enormous impact this bill will have on saving the lives of the millions of people needlessly dying from malaria. It is critical that the new Congress takes the steps needed to ensure that the promise of PEPFAR funding is achieved and we are certain that Vice President-elect Biden will continue to support the life-saving objectives of this legislation. We also salute Senator McCain for a hard fought campaign and for his commitment to ending malaria. We look forward to continuing to work with him as the U.S. Senate moves to fully fund PEPFAR. In addition, the President's Malaria Initiative has demonstrated significant results in a short period of time. PMI's work is maki
'/>"/>

SOURCE Malaria No More
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genetic Research Offers Insights Into Form of Malaria
2. Marathon and Partners Announce $28 Million, 5-Year Extension of Life Saving Malaria Control Project in Equatorial Guinea
3. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
4. Study: Delaying evolution of drug resistance in malaria parasite possible
5. Malaria No More Names Scott Case Chief Executive Officer
6. FC Barcelona & FCB Foundation, Malaria No More and AYSO Launch Initiative to Kick it to Malaria
7. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
8. U of M researchers find cerebral malaria may be a major cause of brain injury in African children
9. Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance
10. Malaria prevention reduces anemia and improves educational potential in Kenyan schoolchildren
11. Discovery of key malaria proteins could mean sticky end for parasite

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Networking is everybody,s buzz word today and...ingClub.com enables Recruiters and Staffers create... share, communicate and close positions. The site ...profiles and network with recruiters. , ... Job Market forces everyone to network more than e...
(Date:11/9/2009)...inds differences in mood despite similar weight lo...- Both a high-fat, low-carbohydrate diet such as t... diet appear to help people lose pounds over the c...ow-fat diets will result in long-term improvement ...of Archives of Internal Medicine . , People on...
(Date:11/9/2009)..., Nov. 9 /PRNewswire-FirstCall/ - Hard To Treat Di...today that Novartis, a US$41 billion international...HTDS, H1N1 Vaccine partner, Zhejiang Tianyuan Bio-...rtis of Switzerland will begin a five-year, $1 bil...ill dramatically increase its investment in its Ch...
(Date:11/9/2009)... Course, to be Offered in April 2010, Provides... Cambridge, MA (Vocus) November ...uman Rights (PHR) first inspected a suspected mas...zed he would need a team of experts to help interp...roperly was a key first step in securing evidence ...
(Date:11/9/2009)...alif., Nov. 9 Actress Mariska Harg...philosophy on Saturday to raise awareness about ...roughout California by building healing and wellne... were created to give one to each of the estimated...geles County,s domestic violence shelters. ,, "...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3
...he Mesothelioma Center within the Herbert Irving C... Hospital and Columbia University Medical Center i...study of a new targeted radiation and chemotherapy...ment for pleural mesothelioma is currently surgery...
...combinant human erythropoietin (rHuEpo) is a genet...h-performance athletes such as cyclists and marath... misuse of the drug is detected in urine collected...ter the procedure. During the last few years, the ...
...nly way to flatten the,trajectory of healthcare sp...timent at last week,s I3 (insight, innovation and .... This statement made by keynote speaker,Wally Gom...ely impact the health and lifestyle choices of,Ame...
...ghout Cities in Guangdong and Guangxi ...., June 26 /Xinhua-PRNewswire-FirstCall/ -- BMP,Su...r the "Company") today,announced the official laun...x, Inc. As part of the launch, the Company,has hel...
... Park, 21,of California who will be playing in the...for Parkinson,s disease. She will donate a portion...to help fund critically needed,Parkinson,s researc...,s grassroots community fundraising program., "I ...
...never smoked but whose cells cannot efficiently re...sk of developing lung cancer than those with effec...rchers from the Department of Epidemiology at The ...in people who have never smoked are poorly underst...
Other Medicine News:Health News:New clinical trial for patients with asbestos-associated lung cancer 2Health News:New study examines the validity of epo testing 2Health News:New study examines the validity of epo testing 3Health News:Aegis Health Group Revealed Next Generation of Employer-Based Health-Improvement Strategies at Nashville Conference 2Health News:BMP Sunstone Announces Official Launch of Ferriprox in PRC 2Health News:BMP Sunstone Announces Official Launch of Ferriprox in PRC 3Health News:LPGA Golfer Jane Park to Raise Funds for Michael J. Fox Foundation for Parkinson's Research 2Health News:Faulty DNA repair could be a risk factor for lung cancer in nonsmokers 2
(Date:11/9/2009)..., PRINCETON JUNCTION, N.J., Nov. 9 /PRNewswire/ ...nest medical devices, but recognizing today,s econ...of high quality aesthetic laser systems, introduce...evice priced at under $50,000. ,, The MOSAIC C...s fractional technology including scanning and sta...
(Date:11/9/2009)..., ANN ARBOR, Mich., Nov. 9 Tho... Clinical Xpert(TM) CareFocus, a leading clinical ...entify at-risk patients in real-time and respond i...total cost of treatment. ,, This upgrade is ava...onal cost. ,, CareFocus 2.0 contains several ...
(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCal...harmaceutical company focused on developing and co...the treatment of immune mediated diseases and canc...sident, Preclinical Development will provide an ov... Merriman Curhan Ford,s 6th Annual Investor Summit...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 1Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 2Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 3Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 4Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 5Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 6Palatin Technologies Inc Reports Fourth Quarter and Fiscal Year End 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13880 7Frost 26 Sullivan Global Heart Health Ingredients Excellence in Financial 26 Risk Management Award Conferred on Pronova BioPharma 56352 1Frost 26 Sullivan Global Heart Health Ingredients Excellence in Financial 26 Risk Management Award Conferred on Pronova BioPharma 56352 2Frost 26 Sullivan Global Heart Health Ingredients Excellence in Financial 26 Risk Management Award Conferred on Pronova BioPharma 56352 3Frost 26 Sullivan Global Heart Health Ingredients Excellence in Financial 26 Risk Management Award Conferred on Pronova BioPharma 56352 4Frost 26 Sullivan Global Heart Health Ingredients Excellence in Financial 26 Risk Management Award Conferred on Pronova BioPharma 56352 5Bluepoint Surgical Group Co Sponsoring Weight Loss Surgery 26amp 3B Healthy Living Expo in Washington DC Area 56351 1Bluepoint Surgical Group Co Sponsoring Weight Loss Surgery 26amp 3B Healthy Living Expo in Washington DC Area 56351 2Bluepoint Surgical Group Co Sponsoring Weight Loss Surgery 26amp 3B Healthy Living Expo in Washington DC Area 56351 3Bluepoint Surgical Group Co Sponsoring Weight Loss Surgery 26amp 3B Healthy Living Expo in Washington DC Area 56351 4
...from Phase 1 Clinical Trial of SNS-595 in Acute,Le...SOUTH SAN FRANCISCO, Calif., June 11, 2007,/PRNews...resented,positive data from clinical studies of tw... SNS-595 and SNS-032, at the 12th,Congress of the ...ustria. , Interim Results from Sunesis, Phase 1 St...
...June 11, 2007-ReGen is pleased to announce that,a ...olostrinin, its,nutraceutical product which the Co...y cognitive function, was presented today at the,2...Surfers,Paradise, Queensland, Australia by Dr Mari... conference, which is being attended by key opinio...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2
...fers a simple and reproducible technique for arthr...tting tip requires no pre-drilling and the anchor ...yester suture. The potential pitfalls of suture ma...liding (I.S.S.™) Eyelet design. The sutures ...
Mini-Revo Suture Anchor System
...fers a simple and reproducible technique for arthr...tting tip requires no pre-drilling and the anchor ...yester suture. The potential pitfalls of suture ma...liding (I.S.S.™) Eyelet design. The sutures ...
...viding complete protection from initial crossing t...es. , ,Proxis is fast and easy to use. It doe...devices for removal of embolic debris. ,Prox.... ,Deployment, capture and recovery are quic...
Medicine Products: